Skip to main content
Premium Trial:

Request an Annual Quote

SuperNova Dx Inks China Collaboration with KSB Diagnostics

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – SuperNova Diagnostics today said that it has signed a collaboration agreement with Shenzhen Kang Bao Bio-Technology.

The Germantown, Md.-based startup did not say what functions KSB Diagnostics will be performing on its behalf, but noted that the Hong Kong firm specializes in the research, manufacture, and distribution of in vitro diagnostic kits and research reagents in China and other markets in the area.

"This collaborative relationship allows SuperNova and KSB to expand R&D, manufacturing, and commercialization into one of the world's largest markets," SuperNova President and CEO Neil Campbell said in a statement.

SuperNova, which initially was based in Hong Kong but set up shop in the US a couple of years ago, has developed the AmpCrystal molecular diagnostics platform. The technology is based on liquid crystal display and uses hyper-dense, energy-mediated nanocrystals in an effort to overcome the limitations inherent in current molecular and immunoassay technologies.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.